FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Important Update on FDA Changes Concerning Peptides HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law